(MedPage Today) — The issue of faulty Automated Impella Controllers was elevated to a class I recall by the FDA, following five serious injuries.
The agency also revised the label for fenofibrates to remove language about cardiovascular benefits…
Source link : https://www.medpagetoday.com/cardiology/generalcardiology/118059
Author :
Publish date : 2025-10-21 15:05:00
Copyright for syndicated content belongs to the linked Source.
